查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132473

下一代組織生物標記市場規模、佔有率和趨勢分析報告：按產品、類型、技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Next Generation Tissue Biomarkers Market Size, Share & Trends Analysis Report By Product (Reagents & Assays, Instruments & Platforms, Software & AI), By Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

下一代組織生物標記市場概述

全球下一代組織生物標記市場預計到 2025 年將達到 33 億美元，到 2026 年將成長到 36 億美元，到 2033 年將達到 60 億美元，2026 年至 2033 年的複合年成長率為 7.5%。

到 2025 年，北美將引領市場，佔銷售額的 46.4%。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 下一代組織生物標記市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 下一代組織生物標記市場分析工具

第4章：下一代組織生物標記市場：產品特定估算與趨勢分析

  • 下一代組織生物標記市場：產品特定趨勢分析
  • 下一代組織生物標記市場：產品規模與趨勢分析（2021-2033年）
  • 試劑和測定
  • 設備和平台
  • 軟體和人工智慧

第5章：下一代組織生物標記市場：按類型分類的估算和趨勢分析

  • 按類型分類的市場佔有率，2025 年和 2033 年
  • 下一代組織生物標記市場：按類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 基因生物標記
  • 蛋白質體學生物標記
  • 表觀遺傳生物標記
  • 轉錄組生物標記
  • 代謝體學物標誌物

第6章 下一代組織生物標記市場：按技術分類的估算和趨勢分析

  • 按技術分類的市場佔有率，2025 年和 2033 年
  • 下一代組織生物標記市場：按技術分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 免疫組織化學
  • 次世代定序（NGS）
  • 基於質譜（MS）的蛋白質體學
  • 太空生物學平台
  • 數位病理學和人工智慧分析
  • 其他

第7章 下一代組織生物標記市場：按應用分類的估算和趨勢分析

  • 按應用領域分類的市場佔有率，2025 年和 2033 年
  • 下一代組織生物標記市場：按應用領域展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 腫瘤學
  • 伴隨診斷
  • 藥物發現與開發
  • 神經病學
  • 其他

第8章 下一代組織生物標記市場：按最終用途分類的估算和趨勢分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 下一代組織生物標記市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院和檢測機構
  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構（CRO）

第9章：下一代組織生物標記市場：區域預測與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第10章 競爭格局

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • Roche Diagnostics/Ventana Medical Systems
    • Agilent Technologies/Dako
    • Thermo Fisher Scientific
    • Leica Biosystems（Danaher Corporation）
    • Illumina
    • Qiagen
    • NeoGenomics
    • NanoString Technologies
    • Akoya Biosciences
    • Bio-Techne/ACD
    • Guardant Health
Product Code: GVR-4-68040-555-5

Next Generation Tissue Biomarkers Market Summary

The global next generation tissue biomarkers market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.6 billion in 2026 to USD 6.0 billion by 2033, at a CAGR of 7.5% from 2026 to 2033. North America dominated the market with the largest revenue share of 46.4% in 2025.

Global Next Generation Tissue Biomarkers Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global next generation tissue biomarkers market report based on product, application, technology, type, end use, and region:

  • Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Reagents & Assays
  • Instruments & Platforms
  • Software & AI
  • Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Genomic Biomarkers
  • Proteomic Biomarkers
  • Epigenetic Biomarkers
  • Transcriptomic Biomarkers
  • Metabolomic Biomarkers
  • Technology Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Immunohistochemistry
  • Next-Generation Sequencing (NGS)
  • Mass Spectrometry (MS)-based Proteomics
  • Spatial Biology Platforms
  • Digital Pathology & AI Analysis
  • Others
  • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Oncology
  • Companion Diagnostics
  • Drug Discovery & Development
  • Neurology
  • Others
  • End-use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Hospitals & Reference Labs
  • Pharma & Biotech Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Type
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. Type outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Next Generation Tissue Biomarker Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise of Precision Medicine and Companion Diagnostics
      • 3.2.1.2. Technological Advancements in Spatial Biology and NGS
      • 3.2.1.3. Expansion of Clinical Utility Across Disease Areas
      • 3.2.1.4. Growth in Digital Pathology and AI-Driven Analysis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Multi-Omic Platforms and Reagents
      • 3.2.2.2. Data Privacy and Infrastructure Barriers in AI Adoption
  • 3.3. Next Generation Tissue Biomarker Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Next Generation Tissue Biomarker Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Next Generation Tissue Biomarker Market: Product Movement Analysis
  • 4.3. Next Generation Tissue Biomarker Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million/Billion)
  • 4.4. Reagents & Assays
    • 4.4.1. Reagents & Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 4.5. Instruments & Platforms
    • 4.5.1. Instruments & Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 4.6. Software & AI
    • 4.6.1. Software & AI Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 5. Next Generation Tissue Biomarker Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Next Generation Tissue Biomarkers Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Genomic Biomarkers
    • 5.5.1. Genomic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.6. Proteomic Biomarkers
    • 5.6.1. Proteomic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.7. Proteomic Biomarkers
    • 5.7.1. Proteomic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.8. Epigenetic Biomarkers
    • 5.8.1. Epigenetic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.9. Transcriptomic Biomarkers
    • 5.9.1. Transcriptomic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 5.10. Metabolomic Biomarkers
    • 5.10.1. Metabolomic Biomarkers Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 6. Next Generation Tissue Biomarker Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Next Generation Tissue Biomarkers Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Immunohistochemistry
    • 6.5.1. Immunohistochemistry Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 6.6. Next-Generation Sequencing (NGS)
    • 6.6.1. Next-Generation Sequencing (NGS) Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 6.7. Mass Spectrometry (MS)-based Proteomics
    • 6.7.1. Mass Spectrometry (MS)-based Proteomics Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 6.8. Spatial Biology Platforms
    • 6.8.1. Spatial Biology Platforms Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 6.9. Digital Pathology & AI Analysis
    • 6.9.1. Digital Pathology & AI Analysis Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 6.10. Others
    • 6.10.1. Others Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 7. Next Generation Tissue Biomarker Market: Application Estimates & Trend Analysis

  • 7.1. Application Market Share, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Next Generation Tissue Biomarkers Market by Application Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Oncology
    • 7.5.1. Oncology Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6. Companion Diagnostics
    • 7.6.1. Companion Diagnostics Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.7. Drug Discovery & Development
    • 7.7.1. Drug Discovery & Development Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.8. Neurology
    • 7.8.1. Neurology Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 7.9. Others
    • 7.9.1. Others Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 8. Next Generation Tissue Biomarker Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2025 & 2033
  • 8.2. Segment Dashboard
  • 8.3. Next Generation Tissue Biomarkers Market by End Use Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 8.5. Hospitals & Reference Labs
    • 8.5.1. Hospitals & Reference Labs Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 8.6. Pharma & Biotech Companies
    • 8.6.1. Pharma & Biotech Companies Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 8.7. Academic and Research Institutes
    • 8.7.1. Academic and Research Institutes Market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 8.8. Contract Research Organizations (CROs)
    • 8.8.1. Contract Research Organizations (CROs) Market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 9. Next Generation Tissue Biomarker Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.5. North America
    • 9.5.1. North America
    • 9.5.2. U.S.
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/Reimbursement
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.5.3. Canada
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/Reimbursement
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.5.4. Mexico
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/Reimbursement
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 9.6. Europe
    • 9.6.1. Europe
    • 9.6.2. UK
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/Reimbursement
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.3. Germany
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/Reimbursement
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.4. France
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/Reimbursement
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. France market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.5. Italy
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/Reimbursement
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.6. Spain
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/Reimbursement
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.7. Norway
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/Reimbursement
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.8. Sweden
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/Reimbursement
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.6.9. Denmark
      • 9.6.9.1. Key country dynamics
      • 9.6.9.2. Regulatory framework/Reimbursement
      • 9.6.9.3. Competitive scenario
      • 9.6.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 9.7. Asia Pacific
    • 9.7.1. Asia Pacific
    • 9.7.2. Japan
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/Reimbursement
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.7.3. China
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/Reimbursement
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. China market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.7.4. India
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/Reimbursement
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. India market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.7.5. Australia
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/Reimbursement
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.7.6. South Korea
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/Reimbursement
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.7.7. Thailand
      • 9.7.7.1. Key country dynamics
      • 9.7.7.2. Regulatory framework/Reimbursement
      • 9.7.7.3. Competitive scenario
      • 9.7.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 9.8. Latin America
    • 9.8.1. Latin America
    • 9.8.2. Brazil
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/Reimbursement
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework/Reimbursement
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million/Billion)
  • 9.9. MEA
    • 9.9.1. MEA
    • 9.9.2. South Africa
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/Reimbursement
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.9.3. Saudi Arabia
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/Reimbursement
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.9.4. UAE
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/Reimbursement
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million/Billion)
    • 9.9.5. Kuwait
      • 9.9.5.1. Key country dynamics
      • 9.9.5.2. Regulatory framework
      • 9.9.5.3. Competitive scenario
      • 9.9.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million/Billion)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2025
    • 10.3.4. Roche Diagnostics / Ventana Medical Systems
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Services benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Agilent Technologies / Dako
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Services benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Thermo Fisher Scientific
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Services benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Leica Biosystems (Danaher Corporation)
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Services benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Illumina
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Services benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Qiagen
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Services benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. NeoGenomics
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Services benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. NanoString Technologies
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Services benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Akoya Biosciences
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Services benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Bio-Techne / ACD
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Services benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Guardant Health
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Services benchmarking
      • 10.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Next Generation Tissue Biomarker market, by region, 2021 - 2033 (USD Million/Billion)
  • Table 3 North America Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 4 North America Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 5 North America Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 6 North America Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 7 North America Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 8 U.S Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 9 U.S Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 10 U.S Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 11 U.S Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 12 U.S Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 13 Canada Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 14 Canada Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 15 Canada Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 16 Canada Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 17 Canada Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 18 Mexico Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 19 Mexico Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 20 Mexico Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 21 Mexico Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 22 Mexico Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 23 Europe Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 24 Europe Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 25 Europe Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 26 Europe Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 27 Europe Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 28 UK Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 29 UK Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 30 UK Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 31 UK Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 32 UK Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 33 Germany Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 34 Germany Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 35 Germany Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 36 Germany Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 37 Germany Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 38 France Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 39 France Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 40 France Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 41 France Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 42 France Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 43 Italy Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 44 Italy Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 45 Italy Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 46 Italy Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 47 Italy Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 48 Spain Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 49 Spain Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 50 Spain Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 51 Spain Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 52 Spain Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 53 Denmark Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 54 Denmark Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 55 Denmark Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 56 Denmark Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 57 Denmark Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 58 Sweden Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 59 Sweden Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 60 Sweden Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 61 Sweden Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 62 Sweden Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 63 Norway Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 64 Norway Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 65 Norway Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 66 Norway Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 67 Norway Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 68 Asia Pacific Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 69 Asia Pacific Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 70 Asia Pacific Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 71 Asia Pacific Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 72 Asia Pacific Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 73 Japan Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 74 Japan Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 75 Japan Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 76 Japan Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 77 Japan Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 78 China Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 79 China Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 80 China Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 81 China Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 82 China Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 83 India Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 84 India Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 85 India Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 86 India Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 87 India Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 88 Australia Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 89 Australia Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 90 Australia Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 91 Australia Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 92 Australia Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 93 South Korea Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 94 South Korea Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 95 South Korea Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 96 South Korea Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 97 South Korea Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 98 Thailand Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 99 Thailand Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 100 Thailand Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 101 Thailand Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 102 Thailand Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 103 Latin America Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 104 Latin America Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 105 Latin America Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 106 Latin America Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 107 Latin America Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 108 Brazil Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 109 Brazil Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 110 Brazil Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 111 Brazil Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 112 Brazil Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 113 Argentina Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 114 Argentina Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 115 Argentina Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 116 Argentina Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 117 Argentina Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 118 MEA Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 119 MEA Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 120 MEA Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 121 MEA Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 122 MEA Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 123 South Africa Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 124 South Africa Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 125 South Africa Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 126 South Africa Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 127 South Africa Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 128 Saudi Arabia Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 129 Saudi Arabia Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 130 Saudi Arabia Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 131 Saudi Arabia Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 132 Saudi Arabia Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 133 UAE Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 134 UAE Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 135 UAE Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 136 UAE Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 137 UAE Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)
  • Table 138 Kuwait Next Generation Tissue Biomarker market, by product, 2021 - 2033 (USD Million/Billion)
  • Table 139 Kuwait Next Generation Tissue Biomarker market, by technology, 2021 - 2033 (USD Million/Billion)
  • Table 140 Kuwait Next Generation Tissue Biomarker market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 141 Kuwait Next Generation Tissue Biomarker market, by type, 2021 - 2033 (USD Million/Billion)
  • Table 142 Kuwait Next Generation Tissue Biomarker market, by end user, 2021 - 2033 (USD Million/Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Next Generation Tissue Biomarker market: market outlook
  • Fig. 14 Next Generation Tissue Biomarker competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Next Generation Tissue Biomarker market driver impact
  • Fig. 20 Next Generation Tissue Biomarker market restraint impact
  • Fig. 21 Next Generation Tissue Biomarker market strategic initiatives analysis
  • Fig. 22 Next Generation Tissue Biomarker market: Product movement analysis
  • Fig. 23 Next Generation Tissue Biomarker market: Product outlook and key takeaways
  • Fig. 24 Reagents & Assays market estimates and forecast, 2021 - 2033
  • Fig. 25 Instruments & Platforms market estimates and forecast, 2021 - 2033
  • Fig. 26 Software & AI market estimates and forecast, 2021 - 2033
  • Fig. 27 Next Generation Tissue Biomarker Market: Type movement analysis
  • Fig. 28 Next Generation Tissue Biomarker market: Type outlook and key takeaways
  • Fig. 29 Genomic Biomarkers market estimates and forecasts, 2021 - 2033
  • Fig. 30 Proteomic Biomarkers market estimates and forecasts,2021 - 2033
  • Fig. 31 Epigenetic Biomarkers market estimates and forecasts, 2021 - 2033
  • Fig. 32 Transcriptomic Biomarkers market estimates and forecasts,2021 - 2033
  • Fig. 33 Metabolomic Biomarkers market estimates and forecasts, 2021 - 2033
  • Fig. 34 Next Generation Tissue Biomarker Market: Technology movement analysis
  • Fig. 35 Next Generation Tissue Biomarker market: Technology outlook and key takeaways
  • Fig. 36 Immunohistochemistry market estimates and forecasts, 2021 - 2033
  • Fig. 37 Next-Generation Sequencing (NGS) market estimates and forecasts,2021 - 2033
  • Fig. 38 Mass Spectrometry (MS)-based Proteomics market estimates and forecasts,2021 - 2033
  • Fig. 39 Spatial Biology Platforms market estimates and forecasts,2021 - 2033
  • Fig. 40 Digital Pathology & AI Analysis market estimates and forecasts,2021 - 2033
  • Fig. 41 Others market estimates and forecasts,2021 - 2033
  • Fig. 42 Next Generation Tissue Biomarker Market: Application movement analysis
  • Fig. 43 Next Generation Tissue Biomarker market: Application outlook and key takeaways
  • Fig. 44 Oncology market estimates and forecasts, 2021 - 2033
  • Fig. 45 Companion Diagnostics market estimates and forecasts,2021 - 2033
  • Fig. 46 Drug Discovery & Development market estimates and forecasts,2021 - 2033
  • Fig. 47 Neurology market estimates and forecasts,2021 - 2033
  • Fig. 48 Others market estimates and forecasts,2021 - 2033
  • Fig. 49 Next Generation Tissue Biomarker market: End-use movement analysis
  • Fig. 50 Next Generation Tissue Biomarker market: End-use outlook and key takeaways
  • Fig. 51 Hospitals & Reference Labs market estimates and forecasts, 2021 - 2033
  • Fig. 52 Pharma & Biotech Companies market estimates and forecasts,2021 - 2033
  • Fig. 53 Academic and Research Institutes market estimates and forecasts, 2021 - 2033
  • Fig. 54 Contract Research Organizations (CROs) market estimates and forecasts, 2021 - 2033
  • Fig. 55 Global Next Generation Tissue Biomarker market: Regional movement analysis
  • Fig. 56 Global Next Generation Tissue Biomarker market: Regional outlook and key takeaways
  • Fig. 57 Global Next Generation Tissue Biomarker market share and leading players
  • Fig. 58 North America market share and leading players
  • Fig. 59 Europe market share and leading players
  • Fig. 60 Asia Pacific market share and leading players
  • Fig. 61 Latin America market share and leading players
  • Fig. 62 Middle East & Africa market share and leading players
  • Fig. 63 North America
  • Fig. 64 Europe
  • Fig. 65 Asia Pacific
  • Fig. 66 Latin America
  • Fig. 67 MEA
  • Fig. 68 North America, by country
  • Fig. 69 North America
  • Fig. 70 North America market estimates and forecasts, 2021 - 2033
  • Fig. 71 U.S.
  • Fig. 72 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 73 Canada
  • Fig. 74 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 75 Mexico
  • Fig. 76 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 77 Europe
  • Fig. 78 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 79 UK
  • Fig. 80 UK market estimates and forecasts, 2021 - 2033
  • Fig. 81 Germany
  • Fig. 82 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 83 France
  • Fig. 84 France market estimates and forecasts, 2021 - 2033
  • Fig. 85 Italy
  • Fig. 86 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 87 Spain
  • Fig. 88 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 89 Denmark
  • Fig. 90 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 91 Sweden
  • Fig. 92 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 93 Norway
  • Fig. 94 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 95 Asia Pacific
  • Fig. 96 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 97 China
  • Fig. 98 China market estimates and forecasts, 2021 - 2033
  • Fig. 99 Japan
  • Fig. 100 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 101 India
  • Fig. 102 India market estimates and forecasts, 2021 - 2033
  • Fig. 103 Thailand
  • Fig. 104 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 105 South Korea
  • Fig. 106 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 107 Australia
  • Fig. 108 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 109 Latin America
  • Fig. 110 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 111 Brazil
  • Fig. 112 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 113 Argentina
  • Fig. 114 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 115 Middle East and Africa
  • Fig. 116 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 117 South Africa
  • Fig. 118 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 119 Saudi Arabia
  • Fig. 120 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 121 UAE
  • Fig. 122 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 123 Kuwait
  • Fig. 124 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 125 Market share of key market players- Next Generation Tissue Biomarker market